The range was previously made by GlaxoSmithKline, which sold its portfolio of over-the-counter drugs to Omega Pharma in 2012.
The range was initially developed by GlaxoSmithKline, which then handed over ownership to Omega Pharma as part of a sale of its non-prescription medication lineup in 2012.